C12N 2750/12011
Geminiviridae
C12N2750/12011 (Geminiviridae) appears on 52 US grants and 67 published applications in this corpus.
Search patents in C12N- Granted patents
- 52
- Published applications
- 67
- Assignees
- 51
- Inventors
- 178
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 2 |
| 2002 | 2 | 5 |
| 2003 | 3 | 3 |
| 2004 | 4 | 6 |
| 2005 | 0 | 4 |
| 2006 | 3 | 3 |
| 2007 | 3 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 1 | 3 |
| 2011 | 1 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 5 |
| 2015 | 1 | 4 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 3 | 0 |
| 2019 | 0 | 4 |
| 2020 | 3 | 3 |
| 2021 | 0 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 2 |
| 2024 | 2 | 6 |
| 2025 | 3 | 4 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12N 2750/12022New viral proteins or individual genes, new structural or functional aspects ofIndexing code25
- C12N 2750/12041Use of virus, viral particle or viral elements as a vectorIndexing code21
- C12N 2750/12021Viruses as suchIndexing code3
- C12N 2750/12061Methods of inactivation or attenuationIndexing code3
- C12N 2750/12023Virus like particles [vlp]Indexing code2
- C12N 2750/12034Use of virus or viral component as vaccineIndexing code2
- C12N 2750/12031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2750/12032Use of virus as therapeutic agent, other than vaccineIndexing code0
All 12 subgroupsShow fewer
Recent patents
- Method for simply constructing two-component viral vector and related applications thereof19 Aug 2025US 12,391,952 B2Institute of Cotton Research, Chinese Academy of Agricultural Sciences
- Optimized plant expression systems13 May 2025US 12,297,443 B2Arizona Board of Regents on behalf of Arizona State University
- Replicating and non-replicating vectors for recombinant protein production in plants and method of use thereof29 Apr 2025US 12,286,636 B2Arizona Board of Regents on Behalf of Arizona
- Virus-based replicon for plant genome editing without inserting replicon into plant genome and uses thereof19 Mar 2024US 11,932,861 B2Industry-Academic Cooperation Foundation Gyeongsang National University
- Anticancer drug-containing plant virus particles30 Jan 2024US 11,883,505 B2Case Western Reserve University
- Replicating and non-replicating vectors for recombinant protein production in plants and method of use thereof13 Nov 2025US 2025/0346915 A1Arizona Board of Regents on behalf of Arizona State University
- Modified plant virus system for delivery of nucleic acids into mammalian cells30 Oct 2025US 2025/0332284 A1
- Method for simply constructing two-component viral vector and related applications thereof29 May 2025US 2025/0171793 A1Institute of Cotton Research, Chinese Academy of Agricultural Sciences
- Insect Toxin Delivery Mediated by a Begomovirus Coat Protein2 Jan 2025US 2025/0002542 A1University of Florida Research Foundation, Inc.
- A method for production of self-replicating, nucleic acid-loaded, virus-like particles (vlp-na) and the uses thereof19 Dec 2024US 2024/0417698 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombinant plant viral nucleic acids86US 5,866,785 ABiosource Technologies, Inc. · 1999
- Recombinant plant viral nucleic acids73US 5,889,190 ABiosource Technologies, Inc. · 1999
- Cytoplasmic inhibition of gene expression by viral RNA42US 6,479,291 B2Large Scale Biology Corporation · 2002